PET/CT in head and neck oncology: State-of-the-art 2013

Laryngoscope

Volumn 124, Issue 4, 2014, Pages 913-915

  Johnson, Jonas T ^a   Branstetter, Barton F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

head and neck oncology; PET CT

Indexed keywords

ADVANCED CANCER; CANCER EPIDEMIOLOGY; CANCER OF UNKNOWN PRIMARY SITE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CERVICAL LYMPH NODE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CYSTIC METASTASIS; DISTANT METASTASIS; ELECTIVE SURGERY; FALSE POSITIVE RESULT; FINE NEEDLE ASPIRATION BIOPSY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LYMPH NODE METASTASIS; METASTASIS; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION EXPOSURE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TREATMENT PLANNING; WHOLE BODY RADIATION;

HEAD AND NECK ONCOLOGY; PET/CT;

HEAD AND NECK NEOPLASMS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896548250     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23942     Document Type: Conference Paper

References (13)

1. Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005; 235: 580-586.
2. Dietl B, Marienhagen J, Kuhnel T, Schreyer A, Kolbl O,. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective. Oral Oncol 2008; 44: 504-508.
3. Johansen J, Buus S, Loft A, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008; 30: 471-478.
4. O'Neill JP, Moynagh M, Kavanagh E, O'Dwyer T,. Prospective, blinded trial of whole-body magnetic resonance imaging versus computed tomography positron emission tomography in staging primary and recurrent cancer of the head and neck. J Laryngol Otol 2010; 124: 1274-1277.
5. Agarwal V, Branstetter BF 4th, Johnson JT,. Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 2008; 41: 23-49, v.
6. Yabuki K, Tsukuda M, Horiuchi C, Taguchi T, Nishimura G,. Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma. Eur Arch Otorhinolaryngol 2010; 267: 1785-1792.
7. Roh JL, Kim JS, Lee JH, et al. Utility of combined (18)F- fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009; 45: 218-224.
8. Rudmik L, Lau HY, Matthews TW, et al. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial. Head Neck 2011; 33: 935-940.
9. Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 2009; 27: 2509-2515.
10. Porceddu SV, Pryor DI, Burmeister E, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 2011; 33: 1675-1682.
11. Beswick DM, Gooding WE, Johnson JT, Branstetter BF 4th,. Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring. Laryngoscope 2012; 122: 1512-1517.
12. McDermott M, Hughes MA, Rath T, et al. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer. Am J Neuroradiol 2013; 34: 1632-1636.
13. Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A,. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2009; 30: 742-748.